Roadmap for cardiovascular prevention trials in chronic kidney disease

Lancet. 2016 Oct 22;388(10055):1964-1966. doi: 10.1016/S0140-6736(16)31331-9.

¹ Inserm 1433, Centre d'Investigations Cliniques-Plurithématique, Université de Lorraine, CHU Nancy, 54500 France; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France; Association Lorraine de Traitement de l'Insuffisance Rénale, Nancy, France. Electronic address: [email protected].
² University of Michigan School of Medicine, Ann Arbor, MI, USA.
³ Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
⁴ Inserm 1433, Centre d'Investigations Cliniques-Plurithématique, Université de Lorraine, CHU Nancy, 54500 France; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

No abstract available

MeSH terms